|
Rivera-Caravaca JM, Viedma-Viedma I, Roldán V. Factors Affecting the Quality of Anticoagulation With Vitamin K Antagonists in Venous Thromboembolism Patients. Biol Res Nurs. 2017 Mar;19(2):198-205. doi: 10.1177/1099800416671211. Epub 2016 Sep 28. PubMed PMID: 27680769.
AÑO: 2017; IF: 1.579
|
27680769
|
García-Fernández A, Roldán V, Rivera-Caravaca JM, Lip GYH, Marín F. Applicability of the modified CHA(2)DS(2)-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients. Eur J Intern Med. 2017 Mar;38:e21-e22. doi: 10.1016/j.ejim.2016.11.006. Epub 2016 Nov 15. PubMed PMID: 27863991.
AÑO: 2017; IF: 3.282
|
|
Esteve-Pastor MA, García-Fernández A, Roldán V, Marín F. Evaluation of HAS-BLED and ORBIT Bleeding Risk Scores in Nonvalvular Atrial Fibrillation Patients Receiving Oral Anticoagulants. Rev Esp Cardiol (Engl Ed). 2017 Feb;70(2):132-133. doi: 10.1016/j.rec.2016.11.006. Epub 2016 Dec 27. English, Spanish. PubMed PMID: 28034682.
AÑO: 2017; IF: 5.166
|
|
Esteve-Pastor MA, García-Fernández A, Macías M, Sogorb F, Valdés M, Roldán V, Muñiz J, Badimon L, Roldán I, Bertomeu-Martínez V, Cequier Á, Lip GY, Anguita M, Marín F; FANTASIIA Investigators. Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients? Circ J. 2016 Sep 23;80(10):2102-8. doi: 10.1253/circj.CJ-16-0471. Epub 2016 Aug 24. PubMed PMID: 27557850.
AÑO: 2016; IF: 3.544
|
|
Roldan V, Marín F. Assessment of bleeding risk in acute ill medical patients. An essential part of venous thromboembolism prevention. Thromb Haemost. 2016 Aug 30;116(3):403-4. doi: 10.1160/TH16-07-0512. Epub 2016 Jul 14. PubMed PMID: 27411774.
AÑO: 2016; IF: 5.627
|